Identification of new therapeutic targets by genome-wide analysis of gene expression in the ipsilateral cortex of aged rats after stroke

• Published in: PloS one 2012-12, Vol.7 (12), p.e50985-e50985
• Main Authors: Buga, Ana-Maria, Scholz, Claus Jürgen, Kumar, Senthil, Herndon, James G, Alexandru, Dragos, Cojocaru, Gabriel Radu, Dandekar, Thomas, Popa-Wagner, Aurel
• Format: Article
• Language: English
• Subjects: Age; Age Factors; Aging - genetics; Aging - metabolism; Animals; Anxiety; Apoptosis; Biology; Blood pressure; Brain; Brain research; Carotid arteries; Cerebral Cortex - metabolism; Cerebral Cortex - physiopathology; Cholesterol; Coenzyme A; Deoxyribonucleic acid; Disease Models, Animal; Disorders; DNA; Enzymes; Fc receptors; Gene clusters; Gene Expression; Genes; Genetic research; Genomes; Genomics; Geriatrics; Group dynamics; Health aspects; Kinases; Medicine; Mental depression; Neurotransmission; Older people; Rats; Rats, Sprague-Dawley; Restoration; Rodents; Steroid 11ß-hydroxylase; Stroke; Stroke - drug therapy; Stroke - genetics; Stroke - physiopathology; Studies; Surgery; Target recognition; Thermal analysis; Veins & arteries
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0050985

Because most human stroke victims are elderly, studies of experimental stroke in the aged rather than the young rat model may be optimal for identifying clinically relevant cellular responses, as well for pinpointing beneficial interventions. We employed the Affymetrix platform to analyze the whole-gene transcriptome following temporary ligation of the middle cerebral artery in aged and young rats. The correspondence, heat map, and dendrogram analyses independently suggest a differential, age-group-specific behaviour of major gene clusters after stroke. Overall, the pattern of gene expression strongly suggests that the response of the aged rat brain is qualitatively rather than quantitatively different from the young, i.e. the total number of regulated genes is comparable in the two age groups, but the aged rats had great difficulty in mounting a timely response to stroke. Our study indicates that four genes related to neuropathic syndrome, stress, anxiety disorders and depression (Acvr1c, Cort, Htr2b and Pnoc) may have impaired response to stroke in aged rats. New therapeutic options in aged rats may also include Calcrl, Cyp11b1, Prcp, Cebpa, Cfd, Gpnmb, Fcgr2b, Fcgr3a, Tnfrsf26, Adam 17 and Mmp14. An unexpected target is the enzyme 3-hydroxy-3-methylglutaryl-Coenzyme A synthase 1 in aged rats, a key enzyme in the cholesterol synthesis pathway. Post-stroke axonal growth was compromised in both age groups. We suggest that a multi-stage, multimodal treatment in aged animals may be more likely to produce positive results. Such a therapeutic approach should be focused on tissue restoration but should also address other aspects of patient post-stroke therapy such as neuropathic syndrome, stress, anxiety disorders, depression, neurotransmission and blood pressure.